Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China, has spread globally very rapidly. The number of COVID-19 patients increased in Japan from late March to early April 2020. Since COVID-19 treatment methods with antivira...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Glob Health Med
Main Authors: Saito, Sho, Hayakawa, Kayoko, Mikami, Ayako, Izumi, Shinyu, Funazaki, Hideki, Ashida, Shinobu, Sugiura, Wataru, Sugiyama, Haruhito, Kokudo, Norihiro, Ohmagari, Norio
Formato: Artigo
Idioma:Inglês
Publicado em: National Center for Global Health and Medicine 2021
Assuntos:
Policy Forum
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071676/
https://ncbi.nlm.nih.gov/pubmed/33937567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.35772/ghm.2020.01106
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados